KPC-producing Klebsiella pneumoniae gut decolonisation following ceftazidime/avibactam-based combination therapy: A retrospective observational study.
J Glob Antimicrob Resist
; 17: 109-111, 2019 06.
Article
en En
| MEDLINE
| ID: mdl-30468915
ABSTRACT
OBJECTIVES:
KPC-producing Klebsiella pneumoniae (KPC-Kp) gut colonisation is a major risk factor for developing systemic infection. Ceftazidime/avibactam (CAZ/AVI) may have a role as decolonisation therapy in special situations.METHODS:
This was a retrospective, observational, multicentre study. The KPC-Kp gut decolonisation rate of CAZ/AVI-based therapy (Group A) was compared with other antimicrobial regimens (Group B) in patients with KPC-Kp infection.RESULTS:
Among 12 patients in Group A, 11 (91.7%) achieved gut decolonisation. None of the 24 patients of Group B were decolonised.CONCLUSION:
CAZ/AVI-based therapy could be useful in KPC-Kp gut decolonisation in high-risk patients.Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Infecciones por Klebsiella
/
Ceftazidima
/
Tracto Gastrointestinal
/
Compuestos de Azabiciclo
/
Klebsiella pneumoniae
/
Antibacterianos
Tipo de estudio:
Observational_studies
/
Risk_factors_studies
Límite:
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
J Glob Antimicrob Resist
Año:
2019
Tipo del documento:
Article
País de afiliación:
Italia